These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23614830)

  • 21. Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging.
    Affram K; Udofot O; Singh M; Krishnan S; Reams R; Rosenberg J; Agyare E
    PLoS One; 2017; 12(9):e0185116. PubMed ID: 28934281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-specific delivery of gemcitabine with activatable liposomes.
    Tucci ST; Kheirolomoom A; Ingham ES; Mahakian LM; Tam SM; Foiret J; Hubbard NE; Borowsky AD; Baikoghli M; Cheng RH; Ferrara KW
    J Control Release; 2019 Sep; 309():277-288. PubMed ID: 31301340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gemcitabine and γ-cyclodextrin/docetaxel inclusion complex-loaded liposome for highly effective combinational therapy of osteosarcoma.
    Sun L; Zhou DS; Zhang P; Li QH; Liu P
    Int J Pharm; 2015 Jan; 478(1):308-317. PubMed ID: 25433201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gemcitabine treatment of rat soft tissue sarcoma with phosphatidyldiglycerol-based thermosensitive liposomes.
    Limmer S; Hahn J; Schmidt R; Wachholz K; Zengerle A; Lechner K; Eibl H; Issels RD; Hossann M; Lindner LH
    Pharm Res; 2014 Sep; 31(9):2276-86. PubMed ID: 24599802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivovalidation.
    Gasselhuber A; Dreher MR; Partanen A; Yarmolenko PS; Woods D; Wood BJ; Haemmerich D
    Int J Hyperthermia; 2012; 28(4):337-48. PubMed ID: 22621735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vitro schedule-dependent interactions between the multitargeted antifolate LY231514 and gemcitabine in human colon adenocarcinoma cell lines.
    Tesei A; Ricotti L; De Paola F; Amadori D; Frassineti GL; Zoli W
    Clin Cancer Res; 2002 Jan; 8(1):233-9. PubMed ID: 11801564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes.
    Dicheva BM; ten Hagen TL; Seynhaeve AL; Amin M; Eggermont AM; Koning GA
    Pharm Res; 2015 Dec; 32(12):3862-76. PubMed ID: 26202516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia.
    Al-Jamal WT; Al-Ahmady ZS; Kostarelos K
    Biomaterials; 2012 Jun; 33(18):4608-17. PubMed ID: 22459195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gemcitabine-based polymer-drug conjugate for enhanced anticancer effect in colon cancer.
    Liang TJ; Zhou ZM; Cao YQ; Ma MZ; Wang XJ; Jing K
    Int J Pharm; 2016 Nov; 513(1-2):564-571. PubMed ID: 27613255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Size of thermosensitive liposomes influences content release.
    Hossann M; Wang T; Wiggenhorn M; Schmidt R; Zengerle A; Winter G; Eibl H; Peller M; Reiser M; Issels RD; Lindner LH
    J Control Release; 2010 Nov; 147(3):436-43. PubMed ID: 20727921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the therapeutic potential of thermosensitive liposomes and hyperthermia in two distinct subtypes of breast cancer.
    Lokerse WJM; Bolkestein M; Dalm SU; Eggermont AMM; de Jong M; Grüll H; Koning GA
    J Control Release; 2017 Jul; 258():34-42. PubMed ID: 28479096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer.
    Cosco D; Bulotta A; Ventura M; Celia C; Calimeri T; Perri G; Paolino D; Costa N; Neri P; Tagliaferri P; Tassone P; Fresta M
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):1009-20. PubMed ID: 19263052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer.
    Awasthi N; Schwarz MA; Schwarz RE
    HPB (Oxford); 2011 Sep; 13(9):597-604. PubMed ID: 21843259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer.
    Réjiba S; Reddy LH; Bigand C; Parmentier C; Couvreur P; Hajri A
    Nanomedicine; 2011 Dec; 7(6):841-9. PubMed ID: 21419876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced gemcitabine-mediated cell killing of human lung adenocarcinoma by vector-based RNA interference against PLK1.
    Zhao XY; Nie CL; Liang SF; Yuan Z; Deng HX; Wei YQ
    Biomed Pharmacother; 2012 Dec; 66(8):597-602. PubMed ID: 23153503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.
    Peller M; Schwerdt A; Hossann M; Reinl HM; Wang T; Sourbron S; Ogris M; Lindner LH
    Invest Radiol; 2008 Dec; 43(12):877-92. PubMed ID: 19002060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIF1α-siRNA and gemcitabine combination-based GE-11 peptide antibody-targeted nanomedicine for enhanced therapeutic efficacy in pancreatic cancers.
    Lin C; Hu Z; Yuan G; Su H; Zeng Y; Guo Z; Zhong F; Jiang K; He S
    J Drug Target; 2019 Aug; 27(7):797-805. PubMed ID: 30481072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Herceptin-conjugated temperature-sensitive immunoliposomes encapsulating gemcitabine for breast cancer.
    Shin DH; Koo MJ; Kim JS; Kim JS
    Arch Pharm Res; 2016 Mar; 39(3):350-8. PubMed ID: 26781980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New treatment strategy with nuclear factor-κB inhibitor for pancreatic cancer.
    Horiuchi T; Uwagawa T; Shirai Y; Saito N; Iwase R; Haruki K; Shiba H; Ohashi T; Yanaga K
    J Surg Res; 2016 Nov; 206(1):1-8. PubMed ID: 27916347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells.
    Masetto F; Chegaev K; Gazzano E; Mullappilly N; Rolando B; Arpicco S; Fruttero R; Riganti C; Donadelli M
    Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118824. PubMed ID: 32828758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.